| Patient Characteristics | Diagnosis | ||
|---|---|---|---|
| 1st line | 2nd line | ||
| No. of patients | 70 | 70 | 70 |
| Age, years, median (range) | 59,1 (19-83) |
59,2 (19-83) |
60,9 (19-83) |
| <65 (%) | 46 65,7 | 46 65,7 | 44 62,9 |
| >65 (%) | 24 34,3 | 24 34,3 | 27 6 37,1 |
| Gender, M/F ratio | 52/18 | 52/18 | 52/18 |
| ECOG (0-1)/(2-3) | 70/0 | 70/0 | 61/9 |
| Metastatic disease | 41 | 65 | 70 |
| Metastatic Site | |||
| LYM only (%) | 24 (34,3) | 27 (38,6) | 16 (22,9) |
| HEP (%) | 5 (7,1) | 10 (14,3) | 21 (30) |
| Visceral other than HEP (%) | 7 (10) | 28 (40) | 33 (47,1) |
| Treatment discontinuation due to toxicity | 2 | 4 |